Publication date: March 2018
Source:European Journal of Cancer, Volume 92, Supplement 2
Author(s): V. Damarla, D. Dobrosotskaya, F. Siddiqui, I. Wollner, M. Raoufi, J. Li, D. Kwon, G. Khan
http://ift.tt/2FCc4Ff
Πέμπτη 15 Μαρτίου 2018
Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου